Indicators

Markets:

News

Latest News about XENE

Recent news which mentions XENE

< Previous 1 2 3 Next >

Earnings Outlook For Xenon Pharmaceuticals

August 08, 2022

Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2022

July 21, 2022

The Daily Biotech Pulse: F-Star Therapeutics Buyout, Orphan Drug Tag For VBI's Brain Cancer Vaccine, Xenon's Epilepsy Candidate Shows Promise

June 23, 2022

Xenon's Epilepsy Candidate Rapidly Reduces Focal Onset Seizure Frequency

June 23, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

June 23, 2022

US Stock Futures Mixed Ahead Of Jobless Claims, Powell Testimony

June 23, 2022

Xenon Pharmaceuticals Shares Drop On Proposed Public Offering

June 22, 2022

Recap of Tuesday's Biotech Catalysts - End of the Day Summary

June 21, 2022

Looking Into Xenon Pharmaceuticals's Return On Capital Employed

June 13, 2022

Recap: Xenon Pharmaceuticals Q1 Earnings

May 10, 2022

The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves

May 10, 2022

Earnings Scheduled For May 10, 2022

May 10, 2022

Xenon Pharmaceuticals's Return On Capital Employed Overview

March 07, 2022

Recap: Xenon Pharmaceuticals Q4 Earnings

March 01, 2022

Earnings Scheduled For March 1, 2022

March 01, 2022

Xenon Pharmaceuticals's Earnings: A Preview

February 28, 2022

Xenon Receives $15M Regulatory Milestone Under Epilepsy Pact With Neurocrine

January 12, 2022

Wednesdays With Wedbush: Analyst Laura Chico On The State Of Biotech

December 29, 2021

Xenon Stock Jumps On New Encouraging Data From Epilepsy Treatment

December 03, 2021

The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering

December 03, 2021

The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week

November 28, 2021

Xenon Pharmaceuticals Has a Great Story But Too High a Price

October 29, 2021

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021

October 28, 2021

Xenon: Heading Toward Phase III With Strong Momentum

October 26, 2021

New Clinical Results Make Xenon Pharmaceuticals’ Stock Worthy Again

October 19, 2021

Shares of Xenon Pharmaceuticals Inc. Have Risen Above Previous 52-Week High

October 14, 2021

3 Growth Stocks Near 52-Week Highs to Buy Anyway

October 14, 2021

The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage

October 10, 2021

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal

October 06, 2021

Xenon Pharmaceuticals Raises $300M Via Equity

October 06, 2021

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.